nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Altered properties of the fibrin gel structure in patients with IDDM
|
Jörneskog, G. |
|
1996 |
39 |
12 |
p. 1519-1523 |
artikel |
2 |
Appropriate Blood Pressure Control in NIDDM (ABCD) Trial
|
Schrier, R. W. |
|
1996 |
39 |
12 |
p. 1646-1654 |
artikel |
3 |
Birth weight and cardiovascular risk factors in an epidemiological study
|
Vestbo, E. |
|
1996 |
39 |
12 |
p. 1598-1602 |
artikel |
4 |
Blockade of vascular ATP-sensitive potassium channels reduces the vasodilator response to ischaemia in humans
|
Bijlstra, P. J. |
|
1996 |
39 |
12 |
p. 1562-1568 |
artikel |
5 |
Co-existence of severe insulin resistance and hyperinsulinaemia in pre-adolescent obese children
|
Caprio, S. |
|
1996 |
39 |
12 |
p. 1489-1497 |
artikel |
6 |
Comparison of the effects of insulin, PDGF, interleukin-6, and interferon-g on glucose transport in 3T3-L1 cells: lack of cross-talk between tyrosine kinase receptors and JAK/STAT pathways
|
Huppertz, C. |
|
1996 |
39 |
12 |
p. 1432-1439 |
artikel |
7 |
Complications in IDDM are caused by elevated blood glucose level: The Stockholm Diabetes Intervention Study (SDIS) at 10-year follow up
|
Reichard, P. |
|
1996 |
39 |
12 |
p. 1483-1488 |
artikel |
8 |
Cytokine gene expression in the BB rat pancreas: natural course and impact of bacterial vaccines
|
Kolb, H. |
|
1996 |
39 |
12 |
p. 1448-1454 |
artikel |
9 |
Diabetic neuropathy in NIDDM
|
Ward, J. D. |
|
1996 |
39 |
12 |
p. 1676-1678 |
artikel |
10 |
Dissociation between insulin sensitivity of glucose uptake and endothelial function in normal subjects
|
Utriainen, T. |
|
1996 |
39 |
12 |
p. 1477-1482 |
artikel |
11 |
Effect of intraperitoneal insulin delivery on growth hormone binding protein, insulin-like growth factor (IGF)-I, and IGF-binding protein-3 in IDDM
|
Hanaire-Broutin, H. |
|
1996 |
39 |
12 |
p. 1498-1504 |
artikel |
12 |
Effects of subcutaneous glucagon-like peptide 1 (GLP-1 [7–36 amide]) in patients with NIDDM
|
Nauck, M. A. |
|
1996 |
39 |
12 |
p. 1546-1553 |
artikel |
13 |
Electronegative low density lipoprotein subform is increased in patients with short-duration IDDM and is closely related to glycaemic control
|
Sánchez-Quesada, J. L. |
|
1996 |
39 |
12 |
p. 1469-1476 |
artikel |
14 |
End-stage renal disease in NIDDM: a consequence of microangiopathy alone?
|
Raine, A. E. G. |
|
1996 |
39 |
12 |
p. 1673-1675 |
artikel |
15 |
GGAAAT motifs play a major role in transcriptional activity of the human insulin gene in a pancreatic islet beta-cell line MIN6
|
Tomonari, A. |
|
1996 |
39 |
12 |
p. 1462-1468 |
artikel |
16 |
Glomerular hyperfiltration in microalbuminuric NIDDM patients
|
Vedel, P. |
|
1996 |
39 |
12 |
p. 1584-1589 |
artikel |
17 |
Glucose and insulin independently reduce the fibrinolytic potential of human vascular smooth muscle cells in culture
|
Pandolfi, A. |
|
1996 |
39 |
12 |
p. 1425-1431 |
artikel |
18 |
Good glycaemic control reduces oxidation and glycation end-products in collagen of diabetic rats
|
Odetti, P. |
|
1996 |
39 |
12 |
p. 1440-1447 |
artikel |
19 |
How often is NIDDM complicated with non-diabetic renal disease?An analysis of renal biopsies and the literature
|
Olsen, S. |
|
1996 |
39 |
12 |
p. 1638-1645 |
artikel |
20 |
Hypertension in Diabetes Study IV. Therapeutic requirements to maintain tight blood pressure controlHypertension in Diabetes Study Group*
|
Stratton, I. |
|
1996 |
39 |
12 |
p. 1554-1561 |
artikel |
21 |
Impact of pancreas transplantation on diabetic secondary complications and quality of life
|
Landgraf, R. |
|
1996 |
39 |
12 |
p. 1415-1424 |
artikel |
22 |
Improving prognosis in NIDDM patients
|
Mogensen, Carl Erik |
|
1996 |
39 |
12 |
p. 1539 |
artikel |
23 |
Lens autofluorescence is increased in newly diagnosed patients with NIDDM
|
Theil, P. Koefoed |
|
1996 |
39 |
12 |
p. 1524-1527 |
artikel |
24 |
Low birth weight – is it associated with few and small glomeruli in normal subjects and NIDDM patients?
|
Nyengaard, J. R. |
|
1996 |
39 |
12 |
p. 1634-1637 |
artikel |
25 |
Macro-microangiopathy and endothelial dysfunction in NIDDM patients with and without diabetic nephropathy
|
Parving, H.-H. |
|
1996 |
39 |
12 |
p. 1590-1597 |
artikel |
26 |
Major lower limb amputation in diabetic patients: development during 1982 to 1993
|
Ebskov, B. |
|
1996 |
39 |
12 |
p. 1607-1610 |
artikel |
27 |
New insights into obesity genes
|
Guerre-Millo, M. |
|
1996 |
39 |
12 |
p. 1528-1531 |
artikel |
28 |
NIDDM: a rapid progressive disease Results from a long-term, randomised, comparative study of insulin or sulphonylurea treatment
|
Birkeland, K. I. |
|
1996 |
39 |
12 |
p. 1629-1633 |
artikel |
29 |
Patterns of renal injury in NIDDM patients with microalbuminuria
|
Fioretto, P. |
|
1996 |
39 |
12 |
p. 1569-1576 |
artikel |
30 |
Pharmacokinetics and safety of glimepiride at clinically effective doses in diabetic patients with renal impairment
|
Rosenkranz, B. |
|
1996 |
39 |
12 |
p. 1617-1624 |
artikel |
31 |
Predictors of 10-year macrovascular and overall mortality in patients with NIDDM: the Munich General Practitioner Project
|
Standl, E. |
|
1996 |
39 |
12 |
p. 1540-1545 |
artikel |
32 |
Promoter (4G/5G) plasminogen activator inhibitor-1 genotype in Pima Indians: relationship to plasminogen activator inhibitor-1 levels and features of the insulin resistance syndrome
|
McCormack, L. J. |
|
1996 |
39 |
12 |
p. 1512-1518 |
artikel |
33 |
Protein C activation in NIDDM patients
|
Gabazza, E. C. |
|
1996 |
39 |
12 |
p. 1455-1461 |
artikel |
34 |
Relationship between diastolic hypertension and myocardial morphology and function in elderly males with diabetes mellitus
|
Lind, L. |
|
1996 |
39 |
12 |
p. 1603-1606 |
artikel |
35 |
Renal and metabolic effects of 1-year treatment with ramipril or atenolol in NIDDM patients with microalbuminuria
|
Schnack, C. |
|
1996 |
39 |
12 |
p. 1611-1616 |
artikel |
36 |
Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up
|
Hanefeld, M. |
|
1996 |
39 |
12 |
p. 1577-1583 |
artikel |
37 |
Safety aspects of oral hypoglycaemic agents
|
Rosskamp, R. |
|
1996 |
39 |
12 |
p. 1668-1672 |
artikel |
38 |
Structural basis of diabetic nephropathy in microalbuminuric NIDDM patients: a light microscopy study
|
Bertani, T. |
|
1996 |
39 |
12 |
p. 1625-1628 |
artikel |
39 |
The causes of obesity: advances in molecular biology but stagnation on the genetic front
|
Bouchard, C. |
|
1996 |
39 |
12 |
p. 1532-1533 |
artikel |
40 |
The Diabetes Atherosclerosis Intervention Study (DAIS): a study conducted in cooperation with the World Health Organization
|
Steiner, G. |
|
1996 |
39 |
12 |
p. 1655-1661 |
artikel |
41 |
The DIAB-HYCAR study
|
Passa, P. |
|
1996 |
39 |
12 |
p. 1662-1667 |
artikel |
42 |
UKPDS 19: Heterogeneity in NIDDM: separate contributions of IRS-1 and b3-adrenergic-receptor mutations to insulin resistance and obesity respectively with no evidence for glycogen synthase gene mutations
|
Zhang, Y. |
|
1996 |
39 |
12 |
p. 1505-1511 |
artikel |